Title: Adjunctive benzodiazepine treatment of hospitalized schizophrenia patients in Asia from 2001 to 2008
year: 2011
Journal: Int J Neuropsychopharmacol
Volume: 14
Issue: 6
Pages: 735-45
Epubdate: 08/02/2011
date: Jul
Alternate Journal: The international journal of neuropsychopharmacology / official scientific journal of the Collegium Internationale Neuropsychopharmacologicum (CINP)
ISSN: 1461-1457
DOI: 10.1017/s146114571000163x
Accession Number: 21294941
Abstract: Benzodiazepines are commonly prescribed to patients with schizophrenia in many countries, but as little is known about such treatment in Asia, we evaluated their adjunctive use for 6761 in-patients diagnosed with schizophrenia in nine Asian countries using a cross-sectional study design in 2001, 2004 and 2008. Multivariate logistic regression and multivariate linear regression analyses were performed to assess predictors of benzodiazepine use and dose, respectively. Overall, 54% of the patients received adjunctive benzodiazepines at an average daily dose equivalent to 30.3 mg diazepam, with minor changes over the years sampled. Benzodiazepine use was highest in Taiwan and Japan, lowest in Thailand and China, and was associated with fewer years ill, presence of delusions (OR 1.24), hallucinations (OR 1.22), disorganized speech (OR 1.17), social or occupational dysfunction (OR 1.16), and use of mood stabilizers (OR 3.15), antiparkinsonian (OR 1.79) or antidepressant drugs (OR 1.33), and lower doses of antipsychotics (all p=0.016 to <0.001). Benzodiazepine doses were highest in Taiwan and China, lowest in Korea and Singapore
higher doses were associated with being young, male, physically aggressive, receiving mood stabilizers, and having electroconvulsive treatment (all p=0.019 to <0.001). Benzodiazepine use was associated with neurological and systemic adverse effects. In conclusion, benzodiazepine use was common in Asian patients with schizophrenia. Predictors of benzodiazepine use and dose differed in this population. Critical clinical guidelines should be developed specifically for Asian countries to address sound practices in regard to use of benzodiazepines for psychotic disorders.
URI: https://open-access.imh.com.sg/handle/123456789/4529
Authors Address: National University Hospital, Singapore. torphernchern@gmail.com
Database Provider: NLM
language: eng
Appears in Collections:2011

Files in This Item:
File Description SizeFormat 
Adjunctive benzodiazepine treatment of hospitalized schizophrenia patients in Asia.pdf117.9 kBAdobe PDFThumbnail

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.